Indoximod, a methylated tryptophan, acts as an IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, and reverses IDO-mediated immune suppression.
This report contains market size and forecasts of Indoximod in global, including the following market information:
Global Indoximod Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Indoximod Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Indoximod companies in 2021 (%)
The global Indoximod market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Indoximod include Merck, BioVision, Abcam, Cayman Chemical, LifeSpan BioSciences, Bio-Techne, Santa Cruz Biotechnology, LGC and Biorbyt, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Indoximod manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Indoximod Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Indoximod Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Indoximod Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Indoximod Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Indoximod Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Indoximod Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Indoximod revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Indoximod revenues share in global market, 2021 (%)
Key companies Indoximod sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Indoximod sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
BioVision
Abcam
Cayman Chemical
LifeSpan BioSciences
Bio-Techne
Santa Cruz Biotechnology
LGC
Biorbyt
Selleck Chemicals
Adooq Bioscience
AbMole
Focus Biomolecules